Literature DB >> 16810007

Increased prostaglandin E2 release and activated Akt/beta-catenin signaling pathway occur after opioid withdrawal in rat spinal cord.

Stuart A Dunbar1, Ivan Karamian, Lou Roberts, Jiahui Zhang.   

Abstract

BACKGROUND: Prostaglandin E(2) is an important spinal modulator of nociception. However, the effects of chronic opioid administration and withdrawal on prostaglandin E(2) release and associated signaling pathways in the spinal cord are generally unknown.
METHODS: This study sought to examine these effects using a spinal microdialysis technique in a model of chronic morphine administration and withdrawal in the rat.
RESULTS: The authors found that spinal prostaglandin E(2) release was unaffected by chronic morphine treatment but was significantly increased during withdrawal. Recurrent withdrawal did not further enhance this release. The authors also found up-regulation of cyclooxygenase-2 expression and phosphorylation of protein kinase Akt at Ser-473 in response to opioid withdrawal. In addition, they demonstrated that beta-catenin, a transcription factor downstream of Akt, was induced during morphine withdrawal, particularly during recurrent withdrawal.
CONCLUSIONS: These results suggest that opioid withdrawal activates signaling pathways associated with neuronal survival and transcriptional control, two processes implicated in neuronal development and synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16810007     DOI: 10.1097/00000542-200607000-00025

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Role of spinal cyclooxygenase-2 and prostaglandin E2 in fentanyl-induced hyperalgesia in rats.

Authors:  Q B Li; L Chang; F Ye; Q H Luo; Y X Tao; H H Shu
Journal:  Br J Anaesth       Date:  2018-04       Impact factor: 9.166

2.  Methamphetamine and HIV-1 Tat down regulate β-catenin signaling: implications for methampetamine abuse and HIV-1 co-morbidity.

Authors:  Amit Sharma; Xiu-Ti Hu; T Celeste Napier; Lena Al-Harthi
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-09       Impact factor: 4.147

3.  IL-4 mediated by HSV vector suppresses morphine withdrawal response and decreases TNFα, NR2B, and pC/EBPβ in the periaqueductal gray in rats.

Authors:  H Yi; T Iida; S Liu; D Ikegami; Q Liu; A Iida; D A Lubarsky; S Hao
Journal:  Gene Ther       Date:  2017-03-16       Impact factor: 5.250

4.  Retracted Article: Upregulation of miR-26b alleviates morphine tolerance by inhibiting BDNF via Wnt/β-catenin pathway in rats.

Authors:  Xing Liu; Jiefeng Geng; Huilian Bu; Junqi Ma; Yanqiu Ai
Journal:  RSC Adv       Date:  2019-12-11       Impact factor: 4.036

5.  Pentazocine Protects SN4741 Cells Against MPP+-Induced Cell Damage via Up-Regulation of the Canonical Wnt/β-Catenin Signaling Pathway.

Authors:  Jiancai Wang; Jintao Gu; Hao Wu; Gang Zhu; Dayun Feng; Yuqian Li; Wei Guo; Keyong Tian; Guodong Gao; Li Gao
Journal:  Front Aging Neurosci       Date:  2017-06-14       Impact factor: 5.750

6.  Withdrawal-associated injury site pain (WISP): a descriptive case series of an opioid cessation phenomenon.

Authors:  Launette Marie Rieb; Wendy V Norman; Ruth Elwood Martin; Jonathan Berkowitz; Evan Wood; Ryan McNeil; M-J Milloy
Journal:  Pain       Date:  2016-12       Impact factor: 7.926

7.  Propoxyphene Mediates Oxyhemoglobin-Induced Injury in Rat Cortical Neurons Through Up-Regulation of Active-β-Catenin.

Authors:  Yuqian Li; Jiancai Wang; Zhihong Li; Hongyu Cheng; Zhuo Zhang; Tao Luo; Xingye Zhang; Guodong Gao; Huashan Lu; Lihong Li
Journal:  Front Pharmacol       Date:  2020-01-30       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.